This is old news but not posted here:
"Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the AMR Action Fund has joined an existing $41 million Series B round as a co-investor".
Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund | Business Wire
Here you will find the corresponding deal with Venatorx Pharmaceuticals
Press Releases | Venatorx Pharmaceuticals
The "AMR" action fund Invested 41M in Adaptive Phage Therapeutics
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $11.59K | 2.677M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 81951460 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 21196025 | 20 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.4¢ | 143255 | ||
| Last updated 12.07pm 06/06/2024 ? | |||||
| ATH (ASX) Chart |